Research output per year
Research output per year
Personal profile
Research interests
My primary clinical research focus is the implementation of novel analytical methodologies to improve treatment decision-making in patients with cancer.
Areas of Clinical Interest
Immunotherapy clinical trials, primary brain tumors and brain metastases, melanoma, merkel cell carcinoma.
Fingerprint
Dive into the research topics where Tanner Johanns is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research output
-
Cytokine Profiling in Plasma from Patients with Brain Tumors Versus Healthy Individuals using 2 Different Multiplex Immunoassay Platforms
Bender, D. E., Schaettler, M. O., Sheehan, K. C. F., Johanns, T. & Dunn, G. P., 2021, In: Biomarker Insights. 16Research output: Contribution to journal › Article › peer-review
Open Access -
Successful administration of sequential TVEC and pembrolizumab followed by temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
Khaddour, K., Dowling, J., Huang, J., Council, M., Chen, D., Cornelius, L., Johanns, T., Dahiya, S. & Ansstas, G., 2021, In: Oncotarget. 11, 35, p. 4836-4844 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
GATA2 Regulates Constitutive PD-L1 and PD-L2 Expression in Brain Tumors
Fu, Y., Liu, C. J., Kobayashi, D. K., Johanns, T. M., Bowman-Kirigin, J. A., Schaettler, M. O., Mao, D. D., Bender, D., Kelley, D. G., Uppaluri, R., Bi, W. L., Dunn, I. F., Tao, Y., Luo, J., Kim, A. H. & Dunn, G. P., Dec 1 2020, In: Scientific reports. 10, 1, 9027.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
The landscape of novel therapeutics and challenges in glioblastoma multiforme: Contemporary state and future directions
Khaddour, K., Johanns, T. M. & Ansstas, G., Nov 2020, In: Pharmaceuticals. 13, 11, p. 1-26 26 p., 389.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine
Liu, C. J., Schaettler, M., Blaha, D. T., Bowman-Kirigin, J. A., Kobayashi, D. K., Livingstone, A. J., Bender, D., Miller, C. A., Kranz, D. M., Johanns, T. M. & Dunn, G. P., Sep 1 2020, In: Neuro-oncology. 22, 9, p. 1276-1288 13 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations